Catatan efek · kuartal yang diarsipkan
BBIO
BridgeBio Pharma, Inc. · Healthcare · Biotechnology
19Pemegang yang dilacak
-1Δ pemegang
71.67MSaham yang dipegang
$3.72BNilai yang dilaporkan
+0Posisi baru
−2Keluar
Input momentum (manajer yang sebanding):
keluasan pemegang -5.0% ·
aliran saham -1.6% ·
posisi baru bersih -10.5%
— formula
Distribusi luas — penurunan saham dan lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 134 | +3 | 120.77M | $8.70B | +10 | −6 |
| Q1 2026 | 133 | +3 | 129.51M | $9.40B | +8 | −6 |
| Q4 2025 | 129 | +2 | 135.35M | $9.88B | +4 | −1 |
| Q3 2025 | 19 | -1 | 71.67M | $3.72B | — | −2 |
| Q2 2025 | 18 | -1 | 70.97M | $3.06B | +1 | −2 |
| Q1 2025 | 16 | +3 | 40.50M | $1.40B | +3 | — |
| Q4 2024 | 13 | 0 | 40.68M | $1.12B | +1 | −1 |
| Q3 2024 | 12 | -1 | 35.94M | $914.95M | — | −1 |
| Q2 2024 | 13 | — | 36.42M | $922.50M | — | — |
Siapa yang memegangnya · Q3 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 16.83M | +2.1% | $874.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (pasif) | 16.83M | +2.1% | $874.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (pasif) | 16.83M | +2.1% | $874.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (pasif) | 16.83M | +2.1% | $874.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (pasif) | 16.83M | +2.1% | $874.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Viking Global Investors ✦ | 15.98M | -13.9% | $829.89M | 2.2% | ▼ Trim | 6 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | BlackRock ✦ (pasif) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | State Street Global Advisors ✦ (pasif) | 5.61M | -4.9% | $291.19M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 26 | State Street Global Advisors ✦ (pasif) | 5.61M | -4.9% | $291.19M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 27 | Geode Capital Management ✦ (pasif) | 3.91M | +6.2% | $203.11M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 28 | Geode Capital Management ✦ (pasif) | 3.91M | +6.2% | $203.11M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 29 | Two Sigma Investments ✦ | 2.33M | -0.4% | $120.97M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 2.25M | +8.2% | $117.01M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 2.25M | +8.2% | $117.01M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 32 | Goldman Sachs Group ✦ | 2.21M | — | $114.74M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Goldman Sachs Group ✦ | 2.21M | — | $114.74M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Goldman Sachs Group ✦ | 2.21M | — | $114.74M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Goldman Sachs Group ✦ | 2.21M | — | $114.74M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Goldman Sachs Group ✦ | 2.21M | — | $114.74M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 1.70M | -16.1% | $88.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 38 | Fidelity (FMR) ✦ | 1.70M | -16.1% | $88.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 39 | Fidelity (FMR) ✦ | 1.70M | -16.1% | $88.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 40 | T. Rowe Price ✦ | 1.57M | +63.1% | $81.42M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 41 | T. Rowe Price ✦ | 1.57M | +63.1% | $81.42M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 42 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 53 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 54 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 55 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 56 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 57 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 58 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 59 | Adage Capital Partners ✦ | 944.85K | +213.5% | $49.08M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 60 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 61 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 62 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 63 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 64 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 65 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 66 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 67 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 68 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 69 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 70 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 71 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 72 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 73 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 74 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 75 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 76 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 77 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 78 | PRIMECAP Management ✦ | 576.37K | -2.1% | $29.94M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 79 | Renaissance Technologies ✦ | 322.25K | +31.0% | $16.74M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 80 | Millennium Management ✦ | 170.44K | -72.5% | $8.85M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 81 | Millennium Management ✦ | 170.44K | -72.5% | $8.85M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 82 | Marshall Wace ✦ | 101.24K | -76.0% | $5.26M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 83 | AQR Capital Management ✦ | 98.83K | -37.4% | $5.13M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 84 | AQR Capital Management ✦ | 98.83K | -37.4% | $5.13M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 85 | AQR Capital Management ✦ | 98.83K | -37.4% | $5.13M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 86 | AQR Capital Management ✦ | 98.83K | -37.4% | $5.13M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 87 | AQR Capital Management ✦ | 98.83K | -37.4% | $5.13M | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Norges Bank | $84.49M | adalah 0.0% |
| Citadel Advisors | $14.35M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 15.30K saham, $1,136 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Aug 19
Kumar Neil
Officer, Director · 8.10K lbr · $679,256
Aug 19
Kumar Neil
Officer, Director · 1.80K lbr · $152,436
Aug 19
Kumar Neil
Officer, Director · 100 lbr · $8,565
Aug 18
Kumar Neil
Officer, Director · 17.28K lbr · $1.42M
Aug 18
Kumar Neil
Officer, Director · 1.90K lbr · $154,184
Aug 18
Kumar Neil
Officer, Director · 14.60K lbr · $1.21M
Aug 18
Kumar Neil
Officer, Director · 1.20K lbr · $100,444
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi
Aug 17
SC 13D/A — KKR Genetic Disorder L.P.
4.2% dari kelas · Lihat pengajuan SEC asli ↗
Aug 03
SC 13G/A — FARALLON CAPITAL MANAGEMENT, L.L.C.
Jul 27
SC 13G/A — BlackRock, Inc.
Jul 10
SC 13D/A — VIKING GLOBAL INVESTORS LP
5.0% dari kelas · Lihat pengajuan SEC asli ↗
May 29
SC 13G — Farallon Capital Partners, L.P.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q3 2025 ·
Metodologi ·
Dapatkan ini melalui API